PMC:7105881 / 1571-1827
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T2 | 76-83 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
| T3 | 126-133 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
| T4 | 166-174 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T2 | 76-83 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T3 | 126-133 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T4 | 166-174 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T11 | 0-256 | Sentence | denotes | These subunit vaccines are introduced on the basis of full-length spike (S) protein, receptor-binding domain (RBD), non-RBD S protein fragments, and non-S structural proteins, and the potential factors affecting these subunit vaccines are also illustrated. |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T34 | 102-108 | SO:0000417 | denotes | domain |
| T35 | 124-133 | PG_1 | denotes | S protein |
| T78790 | 102-108 | SO:0000417 | denotes | domain |
| T16061 | 124-133 | PG_1 | denotes | S protein |